Products

Seoul virus: When pet rats become a risk

Anyone who has got a pet rat at home knows how intelligent and adaptable these animals are. And they are becoming increasingly popular as pets. However, as with all animals in human care, there is a risk of them transmitting pathogens, such as hantaviruses, to humans. Hantaviruses, which occur worldwide, belong to the group of […]

Products

Increasing spread of infectious diseases due to climate change

Experts worldwide have identified climate change as the greatest health challenge of the 21st century. There is growing evidence that climatic changes also favour the emergence, recurrence and spread of infectious diseases. However, the full extent of this worrying development is still insufficiently investigated. In a study from 2022, researchers analysed the literature and found

Products

Exotic emerging diseases

Emerging infectious diseases is a term for new infectious diseases in humans that have either newly appeared in a population or have already existed but are rapidly increasing in incidence or geographic range. The term also covers diseases that are caused by novel pathogens. These have developed from bacteria or viruses that were previously harmless

Coronavirus complete serological tests Covid-19 - ELISA CE-marked
Products

EUROIMMUN now offers a complete test package for direct detection of the new coronavirus and antibodies against SARS-CoV-2

Notification EUROIMMUN AG from Lübeck in Germany, a manufacturer of reagents and automated systems for medical laboratory diagnostics, has developed a PCR test for direct virus detection, in addition to the assays for the detection of antibodies against SARS-CoV-2 (ELISA). The new test is a real-time reverse transcriptase PCR used to detect the genetic material

Coronavirus complete serological tests Covid-19 - ELISA CE-marked
Products

Tests for detection of antibodies against SARS-CoV-2 now available

Press release EUROIMMUN AG (Lübeck, Germany), a manufacturer of reagents and instruments for medical laboratory diagnostics, has developed serological tests for detection of antibodies against the novel coronavirus SARS-CoV-2. The two ELISAs enable detection of specific IgA and IgG against the virus in the blood of infected patients. In December 2019 the WHO in China

Scroll to Top